Rv. Gardner, INTERFERON-GAMMA (IFN-GAMMA) AS A POTENTIAL RADIO-PROTECTANT AND CHEMO-PROTECTANT, American journal of hematology, 58(3), 1998, pp. 218-223
Interferons (IFN) have had increasing clinical usage in the treatment
of a variety of disorders, at times being used in combination with che
mo- or radiotherapy. However, interferons may have inhibitory effects
on hematopoietic stem cell proliferation and the effects of this cytok
ine's use on long-term hematologic function have not been studied. We
performed the competitive repopulation assay in the murine system, usi
ng cells exposed to irradiation or single-dose chemotherapy with or wi
thout concomitant IFN-gamma use. IFN-gamma alone had no deleterious ef
fects on hematopoietic stem cell productivity. We measured the repopul
ating ability of exhaustible multilineage precursors that were present
at early stages of marrow repopulation after competitive repopulation
(30 days). These progenitors were minimally impacted by cyclophospham
ide (CTX) with or without IFN-gamma. Irradiation (XRT) and CTX alone p
roduced significant repopulating defects in the most primitive hematop
oietic stem cell, PHSC. Addition of IFN to either treatment regimen re
sulted in protection of PHSC, with improved repopulating ability, alth
ough the levels of donor marrow reached control levels only when CTX a
nd IFN were used together. The results of multiple use of IFN with che
motherapy must be studied further, but IFN may offer hematologic radio
- and chemoprotection, in addition to its antitumor properties in clin
ical protocols for treatment of cancers. Am. J. Hematol. 58:218-223, 1
998. (C) 1998 Wiley-Liss, Inc.